Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Taxa Biotechnologies
AddedFeb 18, 2024
UpdatedJul 3, 2026
Taxa Biotechnologies

Taxa Biotechnologies

Closed

TAXA: Streamlining plant genetic engineering for all, bypassing costly regulations.

HQ
San Francisco, CA, US
Founded
2012
Accelerator
Y Combinator logoY CombinatorS14
Overview
Compare
Fundraising
Employees

Taxa Biotechnologies' mission is to democratize plant genetic engineering by providing a platform that allows anyone to perform metabolic engineering of plants without lab access. Their services include protein engineering, DNA assembly, transient experiments, and stable transformation. The company focuses on making these technologies accessible and free from expensive regulatory approval, enabling immediate market availability in the U.S.

Taxa Biotechnologies has significantly impacted the biotech industry by streamlining the genetic engineering process, making it more affordable and faster. Their "Powered by TAXA" products bypass regulatory hurdles, facilitating quicker consumer access. This innovation has positioned them as a key player in the field of plant biotechnology.

Taxa Biotechnologies - Similar Companies

Ginkgo Bioworks logo

Ginkgo Bioworks

ginkgobioworks.com

Solis Agrosciences logo

Solis Agrosciences

Myfloradna logo

Myfloradna

myfloradna.com

Plant Sensory Systems logo

Plant Sensory Systems

Rev Genomics logo

Rev Genomics

revgenomics.com

Arcturus BioCloud logo

Arcturus BioCloud

arcturus.io

GreenLab logo

GreenLab

greenlab.com

Delta Leaf Laboratories logo

Delta Leaf Laboratories

Napigen logo

Napigen

napigen.com

Nitrogenics logo

Nitrogenics

Plastomics logo

Plastomics

plastomics.com

Culture Biosciences logo

Culture Biosciences

GeneTether logo

GeneTether

genetether.com

Botanisol Analytics logo

Botanisol Analytics

Inscripta logo

Inscripta

inscripta.com

Taxa Biotechnologies - Quick Facts

Who are Taxa Biotechnologies' competitors?

Companies similar to Taxa Biotechnologies include Ginkgo Bioworks, Solis Agrosciences, Myfloradna and Plant Sensory Systems.

When was Taxa Biotechnologies founded?

Taxa Biotechnologies was founded in 2012.

Where is Taxa Biotechnologies' headquarters located?

Taxa Biotechnologies' headquarters is located in San Francisco, CA, US.

When was Taxa Biotechnologies' last funding round?

Taxa Biotechnologies' most recent funding round was for $425k (USD) in July 2014.

How much has Taxa Biotechnologies raised to-date?

As of Jul 16, 2014, Taxa Biotechnologies has raised a total of $909k (USD).

Taxa Biotechnologies - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
Tags
  • AgTech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325413In-Vitro Diagnostic Substance Manufacturing
  • 513200Software Publishers
  • 510000Information
  • 325000Chemical Manufacturing
  • 513000Publishing Industries
  • 325410Pharmaceutical and Medicine Manufacturing
  • 513210Software Publishers
SIC
  • 2835In Vitro And In Vivo Diagnostic Substances
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 7372Prepackaged Software